BRM holders:A joint venture with a large Japanese steel company, or capital injection from a Japanese investor, was the reason behind the rise in BRM's sp yesterday.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%